Cre recombinase-mediated DNA recombination is proving to be a powerful tech
nique for the generation of mosaic mutant mice. To develop this technology
further, we have altered the cre gene to enhance its expression in mammalia
n cells and have tested its efficiency of expression in a bicistronic messa
ge. Using a transient transfection assay, we found that the extension of a
eukaryotic translation initiation consensus sequence, the insertion of two
N-terminal amino acids, and the mutation of a cryptic splice acceptor site
did not detectably alter Cre recombinase activity. The addition of either o
f two introns resulted in an similar to 2-fold increase in recombination fr
equency. We then tested the relative efficacy of Cre-mediated recombination
in several bicistronic messages having the encephalomyocarditis virus inte
rnal ribosome entry site (IRES), Recombination frequencies were only reduce
d 2-fold relative to a comparable monocistronic cre gene. The latter result
s indicate that it will be possible to generate transgenic mouse strains ha
ving tissue-specific expression of the Cre recombinase through integration
of an IRES-cre gene without disabling the targeted gene.